课题基金 / 基金详情

Regulation of ACAT in multiple risk factor syndrome

Regulation of ACAT in multiple risk factor syndrome
ACAT 在多危险因素综合征中的调节
批准号:
14571101
负责人:
MIYAZAKI Akira
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

MIYAZAKI Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acyl-coenzyme A: cholesterol acyltransferase 1 (ACAT1) was regarded as a major ACAT isoform expressed in human macrophages. However, the current immunohistochemical studies with an ACAT2 antibody demonstrated significant expression of ACAT2 in macrophage-foam cells in human atherosclerotic lesions. All the macrophages in the lesions expressed ACAT1 while 70-80% of the macrophages expressed ACAT2. Immunoblot and RT-PCR analyses of cultured human monocyte-macrophages demonstrated that immature macrophages expressed only ACAT1 while fully differentiated macrophages expressed both ACAT1 and ACAT2. Additional immunoblot and RT-PCR analyses showed that mouse peritoneal exudate macrophages expressed both ACAT1 and ACAT2 while mouse resident peritoneal macrophages expressed only ACAT1. We conclude that under various pathological conditions, fully differentiated macrophages express ACAT2 in addition to ACAT1.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
Kuniyasu, A. et al.: "CD36-mediated endocytic uptake of advanced glycation end products. (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes."Federation of European Biochemical Society Letters. 537. 85-90 (2003)
Kuniyasu, A. 等人:“小鼠 3T3-L1 和人皮下脂肪细胞中 CD36 介导的晚期糖基化终产物 (AGE) 的内吞摄取。”欧洲生化学会快报联合会。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kuniyasu A, Ohgami N, Hayashi S, Miyazaki A, Horiuchi S, Nakayama H.: "CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes."Federation of European Biochemical Society Letters. 537. 85-9
Kuniyasu A、Ohgami N、Hayashi S、Miyazaki A、Horiuchi S、Nakayama H.:“CD36 介导的小鼠 3T3-L1 和人皮下脂肪细胞中晚期糖基化终末产物 (AGE) 的内吞摄取。”欧洲生化学会快报联合会
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Miyazaki A, Sakai M, Sakamoto Y, Horiuchi S.: "Acyl-coenzyme A: cholesterol acyl transferase inhibitors for controlling hypercholesterolemia and atherosclerosis."Current Opinion in Investigational Drugs. 4. 1095-1099 (2003)
Miyazaki A、Sakai M、Sakamoto Y、Horiuchi S.:“酰基辅酶 A:用于控制高胆固醇血症和动脉粥样硬化的胆固醇酰基转移酶抑制剂。”研究药物的当前观点。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohgami, N. et al.: "Advenced glycation end products (AGE) inhbits scavenger receptor class B type I-mediated reverse cholesterol transport : a new cressroad of AGE to cholesterol metabolism."Journal of Atherosclerosis and Thrombosis. 10. 1-6 (2003)
Ohgami, N. 等人:“晚期糖基化终末产物 (AGE) 抑制 B 类清道夫受体 I 型介导的反向胆固醇转运:AGE 与胆固醇代谢的新十字路口。”动脉粥样硬化和血栓形成杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Evaluation and improvement of nitrogen and water use efficiencies in Chinese high-yielding rice cultivars
    • 批准号:
      22580015
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.41万
    • 财政年份:
      2010
    • 负责人:
      MIYAZAKI Akira
    • 依托单位:
    Regulation of macrophage foam cell formation and atherosclerosis by novel regulatory peptides for cardiovascular system
    • 批准号:
      20591084
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      MIYAZAKI Akira
    • 依托单位:
    Development of novel molecular conductors based onπ-electron system using self-polarized donor molecules
    Development of molecular conducting magnets oriented to π-d interaction control
    • 批准号:
      14540530
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2002
    • 负责人:
      MIYAZAKI Akira
    • 依托单位:
    国内基金
    海外基金
    基于ACAT2/FASN/AcAc-CoA调控轴探讨促进脂肪酸合成代谢对抗血管内皮衰老的分子机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2023
    • 负责人:
      罗文威
    • 依托单位:
    乳腺癌CDK4/6抑制剂耐药新机制:ACAT2代谢物Meta2靶向调控YAP构象及活性促进其核转位的机制研究
    • 批准号:
      82303834
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      孙茜
    • 依托单位:
    ACAT2介导的DGKA乙酰化修饰促进卵巢癌铂耐药的机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      李洁
    • 依托单位:
    ACAT2介导的胆固醇酯化参与干扰素对炎症信号调控的机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      58万元
    • 批准年份:
      2021
    • 负责人:
      周全
    • 依托单位: